Intrexon Corporation (NASDAQ: XON), a publicly traded biopharmaceutical and bioengineering company, engaged Cascadia Capital to provide transaction advisory services in its divestiture of a stake in AquaBounty Technologies, LLC (NASDAQ: AQB), a genetically modified salmon producer. The sale took place on October 29th, 2019 as announced in Intrexon’s public filings.
Founded in 1991, AquaBounty Technologies is an aquaculture company that uses a proprietary gene technology to radically improve land-based farming of Atlantic salmon. The resulting faster growth and greater feed efficiency mean a more efficient use of capital, reduced feed costs and less time to market, when compared to the Company’s competitors.
The sale represents another successful transaction for Cascadia in the Food, Beverage & Agribusiness sector. Recent transactions include Auvil Fruit Company, Firestone Pacific Foods, Western Polymer Corp, More Than Gourmet, and Specialty Sales.
For more information about this transaction, please contact the Cascadia Capital deal team:
CEO & Managing Director
Senior Vice President